Trial intelligence / Profile preview

Parent-Child Interaction Therapy versus methylphenidate in preschool children with ADHD and disruptive behavior problems after insufficient Parent Management Training

2010-019930-28Phase 4Active

Sponsor
Accare
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of methylphenidate in attention deficit hyperactivity disorder (ADHD) and Disruptive behavior disorders (DBD) (2 arms), sponsored by Accare. Primary endpoint: Caretaker's Eyberg Child Behavior Inventory. Started Mar 2010; status: active.

02

Drugs

methylphenidate
03

Conditions

attention deficit hyperactivity disorder (ADHD)Disruptive behavior disorders (DBD)

Beyond the preview

Go deeper on 2010-019930-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-019930-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call